Until regulators and customers in emerging markets demand better products, tens of thousands will be killed by substandard drugs, and unfortunately some of these products will make their way to U.S. markets, too. Chinese and Indian producers dominate many drug categories in emerging markets, notably anti-infectives. The ring manufactured more than 80 brands -- including Plavix -- of fake medicine very convincingly, only distinguishable from real drugs by experts. Some markets are barely affected, while others are replete with substandard products. Playing Russian roulette with fake drugs "Pharmaceutical counterfeiting is a low-risk, high-profit criminal enterprise that attracts entrepreneurs and organized criminals," says John P. Clark, vice president and chief security officer for the drug company Pfizer.